SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    F. Molica, S. Morel, B. R. Kwak, F. Rohner-Jeanrenaud, S. Steffens, Adipokines at the crossroad between obesity and cardiovascular disease, Thrombosis and Haemostasis, 2014, 113, 2

    CrossRef

  2. 2
    G.C. Kabat, M. Heo, M.A. Allison, L. Hou, R. Nassir, O. Zaslavsky, T.E. Rohan, Association of anthropometric measures and hemostatic factors in postmenopausal women: A longitudinal study, Nutrition, Metabolism and Cardiovascular Diseases, 2014, 24, 10, 1120

    CrossRef

  3. 3
    Pilar Taura, Eva Rivas, Graciela Martinez-Palli, Annabel Blasi, Juan Carlos Holguera, Jaume Balust, Salvadora Delgado, Antonio M. Lacy, Clinical markers of the hypercoagulable state by rotational thrombelastometry in obese patients submitted to bariatric surgery, Surgical Endoscopy, 2014, 28, 2, 543

    CrossRef

  4. 4
    Marta Greco, Eusebio Chiefari, Tiziana Montalcini, Francesca Accattato, Francesco S. Costanzo, Arturo Pujia, Daniela Foti, Antonio Brunetti, Elio Gulletta, Early Effects of a Hypocaloric, Mediterranean Diet on Laboratory Parameters in Obese Individuals, Mediators of Inflammation, 2014, 2014, 1

    CrossRef

  5. 5
    Denise L. Smith, Gavin P. Horn, Steven J. Petruzzello, Gregory G. Freund, Jeffrey A. Woods, Marc D. Cook, Eric Goldstein, Bo Fernhall, Effect of Obesity on Acute Hemostatic Responses to Live-Fire Training Drills, The American Journal of Cardiology, 2014, 114, 11, 1768

    CrossRef

  6. 6
    Ahmed A. El-Gendy, Amr M. Abbas, Effect of omega-3 fatty acids on haemostatic functions in urocortin-treated obese rats, Journal of Physiology and Biochemistry, 2014, 70, 3, 809

    CrossRef

  7. 7
    E. Campello, E. Zabeo, C. M. Radu, L. Spiezia, S. Gavasso, M. Fadin, B. Woodhams, R. Vettor, P. Simioni, Hypercoagulability in overweight and obese subjects who are asymptomatic for thrombotic events, Thrombosis and Haemostasis, 2014, 113, 1

    CrossRef

  8. 8
    Yoosoo Chang, Bo-Kyoung Kim, Kyung Eun Yun, Juhee Cho, Yiyi Zhang, Sanjay Rampal, Di Zhao, Hyun-Suk Jung, Yuni Choi, Jiin Ahn, João A.C. Lima, Hocheol Shin, Eliseo Guallar, Seungho Ryu, Metabolically-Healthy Obesity and Coronary Artery Calcification, Journal of the American College of Cardiology, 2014, 63, 24, 2679

    CrossRef

  9. 9
    Un Jung, Myung-Sook Choi, Obesity and Its Metabolic Complications: The Role of Adipokines and the Relationship between Obesity, Inflammation, Insulin Resistance, Dyslipidemia and Nonalcoholic Fatty Liver Disease, International Journal of Molecular Sciences, 2014, 15, 4, 6184

    CrossRef

  10. 10
    Sheri Tokumaru, Kara Izumi, Kazuma Nakagawa, Obesity increases risk of anticoagulation reversal failure with prothrombin complex concentrate in those with intracranial hemorrhage, International Journal of Neuroscience, 2014, 1

    CrossRef

  11. 11
    Michael G. S. Shashaty, Renee D. Stapleton, Physiological and Management Implications of Obesity in Critical Illness, Annals of the American Thoracic Society, 2014, 11, 8, 1286

    CrossRef

  12. 12
    An Verrijken, Sven Francque, Ilse Mertens, Janne Prawitt, Sandrine Caron, Guy Hubens, Eric Marck, Bart Staels, Peter Michielsen, Luc Van Gaal, Prothrombotic factors in histologically proven nonalcoholic fatty liver disease and nonalcoholic steatohepatitis, Hepatology, 2014, 59, 1
  13. 13
    A. J. Butwick, B. Carvalho, Y. Y. El-Sayed, Risk factors for obstetric morbidity in patients with uterine atony undergoing Caesarean delivery, British Journal of Anaesthesia, 2014, 113, 4, 661

    CrossRef

  14. 14
    Yavuz Yigit, Fatma Demet Arslan Ince, Mehmet Hicri Koseoglu, Aysenur Atay, Hamit Yasar Ellidağ, The Acute Effects of Postprandial Hypertriglyceridemia on Coagulation Parameters in Normal and Overweight Individuals, Indian Journal of Clinical Biochemistry, 2014,

    CrossRef

  15. 15
    Michael Safaee, Matthew Z. Sun, Taemin Oh, Manish K. Aghi, Mitchel S. Berger, Michael W. McDermott, Andrew T. Parsa, Orin Bloch, Use of thrombin-based hemostatic matrix during meningioma resection: A potential risk factor for perioperative thromboembolic events, Clinical Neurology and Neurosurgery, 2014, 119, 116

    CrossRef

  16. 16
    Andrew D. Blann, A procoagulant state and endothelial dysfunction in obese children, British Journal of Haematology, 2013, 160, 5
  17. 17
    Amita Singh, Robert Donnino, Howard Weintraub, Arthur Schwartzbard, Effect of Strict Glycemic Control in Patients With Diabetes Mellitus on Frequency of Macrovascular Events, The American Journal of Cardiology, 2013, 112, 7, 1033

    CrossRef

  18. 18
    Caroline Richard, Marie-Michelle Royer, Patrick Couture, Katherine Cianflone, Reza Rezvani, Sophie Desroches, Benoît Lamarche, Effect of the Mediterranean diet on plasma adipokine concentrations in men with metabolic syndrome, Metabolism, 2013, 62, 12, 1803

    CrossRef

  19. 19
    R. Pas, F.W.G. Leebeek, L.J. Hofland, W.W. Herder, R.A. Feelders, Hypercoagulability in Cushing's syndrome: prevalence, pathogenesis and treatment, Clinical Endocrinology, 2013, 78, 4
  20. 20
    G. Jamar, L. P. Pisani, L. M. Oyama, C. Belote, D. C. L. Masquio, V. A. Furuya, J. P. Carvalho-Ferreira, S. G. Andrade-Silva, A. R. Dâmaso, D. A. Caranti, Is the neck circumference an emergent predictor for inflammatory status in obese adults?, International Journal of Clinical Practice, 2013, 67, 3
  21. 21
    A. Russolillo, S. Iervolino, R. Peluso, R. Lupoli, A. Di Minno, N. Pappone, M. N. D. Di Minno, Obesity and psoriatic arthritis: from pathogenesis to clinical outcome and management, Rheumatology, 2013, 52, 1, 62

    CrossRef

  22. 22
    A. Tuinenburg, S. Biere-Rafi, M. Peters, P. Verhamme, K. Peerlinck, M. J. H. A. Kruip, B. A. P. Gorkom, M. Roest, J. C. M. Meijers, P. W. Kamphuisen, R. E. G. Schutgens, Obesity in haemophilia patients: effect on bleeding frequency, clotting factor concentrate usage, and haemostatic and fibrinolytic parameters, Haemophilia, 2013, 19, 5
  23. 23
    Thomas Gremmel, Sabine Steiner, Daniela Seidinger, Renate Koppensteiner, Simon Panzer, Christoph W. Kopp, Obesity is associated with poor response to clopidogrel and an increased susceptibility to protease activated receptor-1 mediated platelet activation, Translational Research, 2013, 161, 5, 421

    CrossRef

  24. 24
    Laura A. Thornsberry, Kristen I. LoSicco, Joseph C. English, The skin and hypercoagulable states, Journal of the American Academy of Dermatology, 2013, 69, 3, 450

    CrossRef

  25. 25
    S. Sharma, J. Uprichard, A. Moretti, H. Boyce, R. Szydlo, G. Stocks, Use of thromboelastography to assess the combined role of pregnancy and obesity on coagulation: a prospective study, International Journal of Obstetric Anesthesia, 2013, 22, 2, 113

    CrossRef

  26. 26
    Kathryn C Fitzgerald, Robert J Glynn, Women and Health, 2013,

    CrossRef

  27. 27
    Tomoko Kitano-Okada, Ayano Ito, Ai Koide, Yumi Nakamura, Kyu-Ho Han, Kenichiro Shimada, Kyoko Sasaki, Kiyoshi Ohba, Shinichi Sibayama, Michihiro Fukushima, Anti-obesity role of adzuki bean extract containing polyphenols: in vivo and in vitro effects, Journal of the Science of Food and Agriculture, 2012, 92, 13
  28. 28
    Anamika Singh, Gary D. Foster, Jay Gunawardana, Tara Alexis McCoy, Tina Nguyen, Stephanie Vander Veur, Eugene Komaroff, Angara Koneti Rao, Elevated circulating tissue factor procoagulant activity, factor VII, and plasminogen activator inhibitor-1 in childhood obesity: evidence of a procoagulant state, British Journal of Haematology, 2012, 158, 4
  29. 29
    F. Semeraro, P. Giordano, M. F. Faienza, L. Cavallo, N. Semeraro, M. Colucci, Evidence that fibrinolytic changes in paediatric obesity translate into a hypofibrinolytic state, Thrombosis and Haemostasis, 2012, 108, 2, 311

    CrossRef

  30. 30
    Massimo Cugno, Roberto Castelli, Daniela Mari, Enrico Mozzi, Marco Antonio Zappa, Massimo Boscolo-Anzoletti, Giancarlo Roviaro, Pier Mannuccio Mannucci, Inflammatory and prothrombotic parameters in normotensive non-diabetic obese women: effect of weight loss obtained by gastric banding, Internal and Emergency Medicine, 2012, 7, 3, 237

    CrossRef

  31. 31
    E.S. Morgan, E. Wilson, T. Watkins, F. Gao, B.J. Hunt, Maternal obesity and venous thromboembolism, International Journal of Obstetric Anesthesia, 2012, 21, 3, 253

    CrossRef

  32. 32
    Sanna M. Kaye, Kirsi H. Pietiläinen, Anna Kotronen, Lotta Joutsi-Korhonen, Jaakko Kaprio, Hannele Yki-Järvinen, Angela Silveira, Anders Hamsten, Riitta Lassila, Aila Rissanen, Obesity-Related Derangements of Coagulation and Fibrinolysis: A Study of Obesity-Discordant Monozygotic Twin Pairs, Obesity, 2012, 20, 1
  33. 33
    F. Santilli, N. Vazzana, R. Liani, M. T. Guagnano, G. Davì, Platelet activation in obesity and metabolic syndrome, Obesity Reviews, 2012, 13, 1
  34. 34
    Isabella Russo, The Prothrombotic Tendency in Metabolic Syndrome: Focus on the Potential Mechanisms Involved in Impaired Haemostasis and Fibrinolytic Balance, Scientifica, 2012, 2012, 1

    CrossRef

  35. 35
    Eric E. Essick, Flora Sam, Cardiac Hypertrophy and Fibrosis in the Metabolic Syndrome: A Role for Aldosterone and the Mineralocorticoid Receptor, International Journal of Hypertension, 2011, 2011, 1

    CrossRef

  36. 36
    Rafael M. Mantovani, Danyelle R.A. Rios, Letícia C.R. Moura, Juliana M. Oliveira, Flávia F. Carvalho, Sarah B. Cunha, Maria de Fátima S. Viana, Joel A. Lamounier, Juni C. Castro, Luci Maria S. Dusse, Ana Cristina Simões e Silva, Childhood obesity: evidence of an association between plasminogen activator inhibitor-1 levels and visceral adiposity, Journal of Pediatric Endocrinology and Metabolism, 2011, 24, 5-6

    CrossRef

  37. 37
    Yuan-Horng Yan, Charles CK Chou, Chung-Te Lee, Jung-Yen Liu, Tsun-Jen Cheng, Enhanced insulin resistance in diet-induced obese rats exposed to fine particles by instillation, Inhalation Toxicology, 2011, 23, 9, 507

    CrossRef

  38. 38
    Paul D. Stein, Fadi Matta, Epidemiology and Incidence: The Scope of the Problem and Risk Factors for Development of Venous Thromboembolism, Critical Care Clinics, 2011, 27, 4, 907

    CrossRef

  39. 39
    Viviane Zorzanelli Rocha, Eduardo J. Folco, Inflammatory Concepts of Obesity, International Journal of Inflammation, 2011, 2011, 1

    CrossRef

  40. 40
    Assimina Galli-Tsinopoulou, Ioannis Kyrgios, Ioanna Maggana, Eleni Z. Giannopoulou, Eleni P. Kotanidou, Charilaos Stylianou, Emmanouil Papadakis, Ioannis Korantzis, George Varlamis, Insulin resistance is associated with at least threefold increased risk for prothrombotic state in severely obese youngsters, European Journal of Pediatrics, 2011, 170, 7, 879

    CrossRef

  41. 41
    P. Fritsch, M. Kleber, A. Schlagenhauf, B. Laschnik, M. Fritsch, W. Muntean, H. Mangge, T. Reinehr, Normalization of haemostatic alterations in overweight children with weight loss due to lifestyle intervention, Atherosclerosis, 2011, 216, 1, 170

    CrossRef

  42. 42
    Paul D. Stein, Fadi Matta, Jose Goldman, Obesity and pulmonary embolism: The mounting evidence of risk and the mortality paradox, Thrombosis Research, 2011, 128, 6, 518

    CrossRef

  43. 43
    M. Di Nisio, A. Di Iorio, E. Porreca, M. Abate, N. Ferrante, S. Bandinelli, J. Guralnik, R. Molino-Lova, F. Cuccurullo, L. Ferrucci, Obesity, Poor Muscle Strength, and Venous Thromboembolism in Older Persons: The InCHIANTI Study, The Journals of Gerontology Series A: Biological Sciences and Medical Sciences, 2011, 66A, 3, 320

    CrossRef

  44. You have free access to this content44
    T. Tzotzas, P. Evangelou, D. N. Kiortsis, Obesity, weight loss and conditional cardiovascular risk factors, Obesity Reviews, 2011, 12, 5
  45. 45
    Nawfal W. Istfan, Wendy A. Anderson, Caroline M. Apovian, Donald T. Hess, R. Armour Forse, Preoperative weight gain might increase risk of gastric bypass surgery, Surgery for Obesity and Related Diseases, 2011, 7, 2, 157

    CrossRef

  46. 46
    Roberto Fogari, Annalisa Zoppi, Amedeo Mugellini, Pamela Maffioli, Pierangelo Lazzari, Giuseppe Derosa, Role of angiotensin II in plasma PAI-1 changes induced by imidapril or candesartan in hypertensive patients with metabolic syndrome, Hypertension Research, 2011, 34, 12, 1321

    CrossRef

  47. 47
    Daynene Vykoukal, Mark G. Davies, Vascular biology of metabolic syndrome, Journal of Vascular Surgery, 2011, 54, 3, 819

    CrossRef

  48. 48
    L. J. Moran, J. D. Cameron, B. J. Strauss, H. J. Teede, Vascular function in the diagnostic categories of polycystic ovary syndrome, Human Reproduction, 2011, 26, 8, 2192

    CrossRef

  49. 49
    C.T. Gomillion, K.J.L. Burg, Comprehensive Biomaterials, 2011,

    CrossRef

  50. 50
    Francis Agyemang-Yeboah, Adipokines, 2011,

    CrossRef

  51. 51
    Jixiang Ma, Aiqiang Xu, Chongqi Jia, Longjian Liu, Zhentao Fu, Jing Dong, Xiaolei Guo, Junying Su, Zhenqiang Bi, Associations of Fibrinogen with Metabolic Syndrome in Rural Chinese Population, Journal of Atherosclerosis and Thrombosis, 2010, 17, 5, 486

    CrossRef

  52. 52
    Paul D. Stein, Fadi Matta, Epidemiology and Incidence: The Scope of the Problem and Risk Factors for Development of Venous Thromboembolism, Clinics in Chest Medicine, 2010, 31, 4, 611

    CrossRef

  53. 53
    P. Tessari, A. Cosma, M. Vettore, R. Millioni, L. Puricelli, P. Cogo, D. Cecchet, V. Carnielli, E. Kiwanuka, Fibrinogen kinetics and protein turnover in obese non-diabetic males: effects of insulin, Diabetes/Metabolism Research and Reviews, 2010, 26, 1
  54. 54
    Marianne T. Severinsen, Kim Overvad, Søren P. Johnsen, Claus Dethlefsen, Poul H. Madsen, Anne Tjønneland, Søren R. Kristensen, Genetic susceptibility, smoking, obesity and risk of venous thromboembolism, British Journal of Haematology, 2010, 149, 2
  55. 55
    P. Fritsch, M. Kleber, A. Rosenkranz, M. Fritsch, W. Muntean, H. Mangge, T. Reinehr, Haemostatic alterations in overweight children: Associations between metabolic syndrome, thrombin generation, and fibrinogen levels, Atherosclerosis, 2010, 212, 2, 650

    CrossRef

  56. 56
    Rubina A. Karatela, Gurmukh S. Sainani, Interrelationships of factor VII activity and plasma leptin with insulin resistance in coronary heart disease, Atherosclerosis, 2010, 209, 1, 235

    CrossRef

  57. 57
    Prachi Singh, Timothy E. Peterson, Kara R. Barber, Fatima Sert Kuniyoshi, Andrus Jensen, Michal Hoffmann, Abu S.M. Shamsuzzaman, Virend K. Somers, Leptin upregulates the expression of plasminogen activator inhibitor-1 in human vascular endothelial cells, Biochemical and Biophysical Research Communications, 2010, 392, 1, 47

    CrossRef

  58. 58
    Susanna Colli, Cesare R. Sirtori, Obesity and thrombotic risk, British Journal of Nutrition, 2010, 104, 12, 1731

    CrossRef

  59. 59
    Iván Palomo, Julián Herrera, Valentina Cancino, Marcelo Alarcón, Verónica Mujica, Elba Leiva, Nora Díaz, Gloria Icaza, Alberto Urzúa, Marcela Vásquez, Daniel R. Gonzalez, Rodrigo Moore-Carrasco, Physical activity reduces circulating TNF-alpha but not pro-thrombotic factors levels in patients with metabolic syndrome, Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 2010, 4, 4, 234

    CrossRef

  60. 60
    Matteo Cesari, Marco Pahor, Raffaele Antonelli Incalzi, REVIEW: Plasminogen Activator Inhibitor-1 (PAI-1): A Key Factor Linking Fibrinolysis and Age-Related Subclinical and Clinical Conditions, Cardiovascular Therapeutics, 2010, 28, 5
  61. 61
    Katrien HJ Gaens, Coen DA Stehouwer, Casper G Schalkwijk, The Nε-(carboxymethyl)lysine–RAGE axis: putative implications for the pathogenesis of obesity-related complications, Expert Review of Endocrinology & Metabolism, 2010, 5, 6, 839

    CrossRef

  62. 62
    Artur Mazur, Paweł Matusik, Ewa Małecka-Tendera, Tkanka tłuszczowa jako narząd wydzielania wewnętrznego, Pediatria Polska, 2010, 85, 3, 255

    CrossRef

  63. 63
    Mitchell K. Craft, Mary Jane Reed, Venous Thromboembolic Disease and Hematologic Considerations in Obesity, Critical Care Clinics, 2010, 26, 4, 637

    CrossRef

  64. 64
    Ichiro Wakabayashi, Hiroshi Masuda, Association of D-dimer with microalbuminuria in patients with type 2 diabetes mellitus, Journal of Thrombosis and Thrombolysis, 2009, 27, 1, 29

    CrossRef

  65. 65
    M. Luque-Ramirez, C. Mendieta-Azcona, J. M del Rey Sanchez, M. Maties, H. F Escobar-Morreale, Effects of an antiandrogenic oral contraceptive pill compared with metformin on blood coagulation tests and endothelial function in women with the polycystic ovary syndrome: influence of obesity and smoking, European Journal of Endocrinology, 2009, 160, 3, 469

    CrossRef

  66. 66
    G. Fanciulli, A. Delitala, G. Delitala, Growth hormone, menopause and ageing: no definite evidence for 'rejuvenation' with growth hormone, Human Reproduction Update, 2009, 15, 3, 341

    CrossRef

  67. 67
    Reza Meshkani, Khosrow Adeli, Hepatic insulin resistance, metabolic syndrome and cardiovascular disease, Clinical Biochemistry, 2009, 42, 13-14, 1331

    CrossRef

  68. 68
    Diana C. Parra, Felipe Lobelo, Luis Fernando Gómez, Candace Rutt, Thomas Schmid, Ross C. Brownson, Michael Pratt, Household motor vehicle use and weight status among Colombian adults: Are we driving our way towards obesity?, Preventive Medicine, 2009, 49, 2-3, 179

    CrossRef

  69. 69
    L. M. STEFFEN, M. CUSHMAN, J. M. PEACOCK, S. R. HECKBERT, D. R. JACOBS JR, W. D. ROSAMOND, A. R. FOLSOM, Metabolic syndrome and risk of venous thromboembolism: Longitudinal Investigation of Thromboembolism Etiology, Journal of Thrombosis and Haemostasis, 2009, 7, 5
  70. 70
    D. Reilly, C. A. Boyle, D. C. Craig, Obesity and dentistry: a growing problem, BDJ, 2009, 207, 4, 171

    CrossRef

  71. 71
    Paul D. Stein, Jose Goldman, Obesity and Thromboembolic Disease, Clinics in Chest Medicine, 2009, 30, 3, 489

    CrossRef

  72. 72
    G. Anfossi, I. Russo, M. Trovati, Platelet dysfunction in central obesity, Nutrition, Metabolism and Cardiovascular Diseases, 2009, 19, 6, 440

    CrossRef

  73. 73
    M Gnacińska, S Małgorzewicz, M Stojek, W Łysiak-Szydłowska, K Sworczak, Role of adipokines in complications related to obesity. A review, Advances in Medical Sciences, 2009, 54, 2

    CrossRef

  74. 74
    Alpaslan Kilicarslan, Bunyamin Yavuz, Gulay Sain Guven, Enver Atalar, Levent Sahiner, Yavuz Beyazit, Murat Kekilli, Necla Ozer, Gul Oz, Ibrahim C Haznedaroglu, Tumay Sozen, Fenofibrate improves endothelial function and decreases thrombin-activatable fibrinolysis inhibitor concentration in metabolic syndrome, Blood Coagulation & Fibrinolysis, 2008, 19, 4, 310

    CrossRef

  75. 75
    Maria Eriksson, Owe Johnson, Kurt Boman, Göran Hallmans, Gideon Hellsten, Torbjörn K. Nilsson, Stefan Söderberg, Improved fibrinolytic activity during exercise may be an effect of the adipocyte-derived hormones leptin and adiponectin, Thrombosis Research, 2008, 122, 5, 701

    CrossRef

  76. 76
    Karen E. Hoffman, Joanne Derdak, Donna Bernstein, James C. Reynolds, Nilo A. Avila, Lynn Gerber, Seth M. Steinberg, George Chrousos, Crystal L. Mackall, Patrick J. Mansky, Metabolic syndrome traits in long-term survivors of pediatric sarcoma, Pediatric Blood & Cancer, 2008, 50, 2
  77. 77
    Marlien Pieters, Hester H. Vorster, Nutrition and hemostasis: A focus on urbanization in South Africa, Molecular Nutrition & Food Research, 2008, 52, 1
  78. 78
    Cornelie Nienaber, Marlien Pieters, Salome H Kruger, Welma Stonehouse, Hester H Vorster, Overfatness, stunting and physical inactivity are determinants of plasminogen activator inhibitor-1activity, fibrinogen and thrombin–antithrombin complex in African adolescents, Blood Coagulation & Fibrinolysis, 2008, 19, 5, 361

    CrossRef

  79. 79
    Ilse Mertens, Isabelle Lemieux, An Verrijken, Jean-Pierre Després, Luc F. Van Gaal, PAI-1 activity, but not fibrinogen or von Willebrand factor, is inversely related to LDL particle size in type 2 diabetes, Diabetes/Metabolism Research and Reviews, 2008, 24, 2
  80. 80
    Yong-Ho Lee, Richard E. Pratley, Abdominal Obesity and Cardiovascular Disease Risk, Journal of Cardiopulmonary Rehabilitation and Prevention, 2007, 27, 1, 2

    CrossRef

  81. 81
    E. Romualdi, A. Squizzato, W. Ageno, Abdominal obesity and the risk of recurrent deep vein thrombosis, Thrombosis Research, 2007, 119, 6, 687

    CrossRef

  82. 82
    A. Greyling, M. Pieters, T. Hoekstra, W. Oosthuizen, A.E. Schutte, Differences in the association of PAI-1 activity with the metabolic syndrome between African and Caucasian women, Nutrition, Metabolism and Cardiovascular Diseases, 2007, 17, 7, 499

    CrossRef

  83. 83
    Takashi Murakami, Hitoshi Horigome, Kiyoji Tanaka, Yoshio Nakata, Yasutomi Katayama, Akira Matsui, Effects of diet with or without exercise on leptin and anticoagulation proteins levels in obesity, Blood Coagulation & Fibrinolysis, 2007, 18, 5, 389

    CrossRef

  84. 84
    Refik Demirtunc, Dursun Duman, Melih Basar, Effects of Doxazosin and Amlodipine on Mean Platelet Volume and Serum??Serotonin Level in Patients with??Metabolic Syndrome, Clinical Drug Investigation, 2007, 27, 6, 435

    CrossRef

  85. 85
    Soraya Taleb, Karine Clément, Emerging role of cathepsin S in obesity and its associated diseases, Clinical Chemical Laboratory Medicine, 2007, 45, 3

    CrossRef

  86. 86
    Tonje Amb Aksnes, Ingebjörg Seljeflot, Peter A. Torjesen, Aud Höieggen, Andreas Moan, Sverre E. Kjeldsen, Improved insulin sensitivity by the angiotensin II–receptor blocker losartan is not explained by adipokines, inflammatory markers, or whole blood viscosity, Metabolism, 2007, 56, 11, 1470

    CrossRef

  87. You have free access to this content87
    André Tchernof, Visceral Adipocytes and the Metabolic Syndrome, Nutrition Reviews, 2007, 65,
  88. 88
    Renata Kuczyńska, Aurelia Sielużycka, Joanna Gąsiorowska, Mieczysława Czerwionka-Szaflarska, Wybrane czynniki ryzyka miażdżycy w wieku rozwojowym, Pediatria Polska, 2007, 82, 3, 177

    CrossRef

  89. 89
    I Mertens, A Verrijken, J J Michiels, M Van der Planken, J B Ruige, L F Van Gaal, Among inflammation and coagulation markers, PAI-1 is a true component of the metabolic syndrome, International Journal of Obesity, 2006, 30, 8, 1308

    CrossRef

  90. 90
    C. P. Tan, C. H. Chia, T. Leese, Chest pain in the early postoperative period after laparoscopic adjustable gastric banding: four case reports, Anaesthesia, 2006, 61, 4
  91. 91
    Susanne Trost, Richard E. Pratley, Burton E. Sobel, Impaired fibrinolysis and risk for cardiovascular disease in the metabolic syndrome and type 2 diabetes, Current Diabetes Reports, 2006, 6, 1, 47

    CrossRef

  92. 92
    Ilse Mertens, Marc Van der Planken, Bob Corthouts, Luc F. Van Gaal, Is visceral adipose tissue a determinant of von Willebrand factor in overweight and obese premenopausal women?, Metabolism, 2006, 55, 5, 650

    CrossRef

  93. 93
    Luc F. Van Gaal, Ilse L. Mertens, Christophe E. De Block, Mechanisms linking obesity with cardiovascular disease, Nature, 2006, 444, 7121, 875

    CrossRef

  94. 94
    M. Berberoǧlu, O. Evliyaoǧlu, P. Adıyaman, G. Öcal, Β. Ulukol, F. Şimşek, Ζ. Şıklar, Α. Törel, D. Özel, N. Akar, Plasminogen Activator Inhibitor-1 (PAI-1) Gene Polymorphism (-675 4G/SG) Associated with Obesity and Vascular Risk in Children, Journal of Pediatric Endocrinology and Metabolism, 2006, 19, 5

    CrossRef

  95. 95
    Melody S. Heffline, Preventing vascular complications after gastric bypass, Journal of Vascular Nursing, 2006, 24, 2, 50

    CrossRef

  96. 96
    B. J. JOHN, S. IRUKULLA, A. M. ABULAFI, D. KUMAR, M. A. MENDALL, Systematic review: adipose tissue, obesity and gastrointestinal diseases, Alimentary Pharmacology & Therapeutics, 2006, 23, 11
  97. 97
    Florence Bieswal, Marie-Thérèse Ahn, Brigitte Reusens, Paul Holvoet, Martine Raes, William D. Rees, Claude Remacle, The Importance of Catch-up Growth after Early Malnutrition for the Programming of Obesity in Male Rat, Obesity, 2006, 14, 8
  98. 98
    C. CIMENTI, H. MANGGE, H. HAIDL, D. ZACH, W. MUNTEAN, Thrombin generation in severely obese children, Journal of Thrombosis and Haemostasis, 2006, 4, 8
  99. 99
    Vincent Ricchiuti, Obesity and Cardiovascular Disease, 2006,

    CrossRef

  100. 100
    Marlien Pieters, Welma Oosthuizen, Johann C Jerling, Du Toit Loots, Janine Mukuddem-Petersen, Susanna M Hanekom, Clustering of haemostatic variables and the effect of high cashew and walnut diets on these variables in metabolic syndrome patients, Blood Coagulation & Fibrinolysis, 2005, 16, 6, 429

    CrossRef

  101. 101
    Mehmet A. Osmanağaoğlu, Selen Osmanağaoğlu, Tayfun Osmanağaoğlu, Bakiye Okumuş, Hasan Bozkaya, Effect of different preparations of hormone therapy on lipid and glucose metabolism, coagulation factors, and bone mineral density in overweight and obese postmenopausal women, Fertility and Sterility, 2005, 84, 2, 384

    CrossRef

  102. 102
    M. H. Cheah, P. C. A. Kam, Obesity: basic science and medical aspects relevant to anaesthetists, Anaesthesia, 2005, 60, 10
  103. 103
    Wayne Huey-Herng Sheu, Huei-Min Linda Chin, Wen-Jane Lee, Chu-Jen Wan, Hsiu-Yueh Su, Hui-Fen Lang, Prospective evaluation of folic acid supplementation on plasma homocysteine concentrations during weight reduction: a randomized, double-blinded, placebo-controlled study in obese women, Life Sciences, 2005, 76, 18, 2137

    CrossRef

  104. 104
    Mi??o ??abovi??, Toma?? Klju??ev??ek, Resolution of Budd???Chiari syndrome due to activation of endogenous fibrinolysis that may be induced by weight reduction, Blood Coagulation & Fibrinolysis, 2005, 16, 1, 51

    CrossRef

  105. 105
    DN Kiortsis, TD Filippatos, MS Elisaf, The effects of orlistat on metabolic parameters and other cardiovascular risk factors, Diabetes & Metabolism, 2005, 31, 1, 15

    CrossRef

  106. 106
    D. R. Cottam, N. T. Nguyen, G. M. Eid, P. R. Schauer, The impact of laparoscopy on bariatric surgery, Surgical Endoscopy, 2005, 19, 5, 621

    CrossRef

  107. 107
    S. Goya Wannamethee, Gordon D.O. Lowe, A. Gerald Shaper, Ann Rumley, Lucy Lennon, Peter H. Whincup, The metabolic syndrome and insulin resistance: relationship to haemostatic and inflammatory markers in older non-diabetic men, Atherosclerosis, 2005, 181, 1, 101

    CrossRef

  108. 108
    James P. Corsetti, Wojciech Zareba, Arthur J. Moss, Charles E. Sparks, Apolipoprotein B determines risk for recurrent coronary events in postinfarction patients with metabolic syndrome, Atherosclerosis, 2004, 177, 2, 367

    CrossRef

  109. 109
    Margaret Voelker, Assessing quality of life in gastric bypass clients, Journal of PeriAnesthesia Nursing, 2004, 19, 2, 89

    CrossRef

  110. 110
    T. Skurk, Y.-M. Lee, T.-O. Nicuta-Rölfs, B. Haastert, A. Wirth, H. Hauner, Effect of the angiotensin II receptor blocker candesartan on fibrinolysis in patients with mild hypertension, Diabetes, Obesity and Metabolism, 2004, 6, 1
  111. 111
    Kim Garrett, Kathy Lauer, Beth-Anne Christopher, The Effects of Obesity on the Cardiopulmonary System: Implications for Critical Care Nursing, Progress in Cardiovascular Nursing, 2004, 19, 4
  112. 112
    Paolo Suter, Pharmacotherapy of Obesity, 2004,

    CrossRef

  113. 113
    Luc F. Van Gaal, Ilse L. Mertens, Pascale J. Abrams, Health risks of lipodystrophy and abdominal fat accumulation: therapeutic possibilities with leptin and human growth hormone, Growth Hormone & IGF Research, 2003, 13, S4

    CrossRef

  114. 114
    Martin Kohlmeier, Nutrient Metabolism, 2003,

    CrossRef

  115. 115
    Ulf Smith, Xiaolin Yang, Adipocytokine Dysregulation, Obesity and the Metabolic Syndrome,
  116. 116
    Terence K. Trow, Richard A. Matthay, Management of Venous Thromboembolism in the Critically Ill Obese Patient,
  117. 117
    Minghan Wang, Mechanisms and Complications of Metabolic Syndrome,